Archive

Author: Marco Propersi

Antacid Monotherapy vs GI Cocktail: Are You On or Off the Wagon?

Background: Dyspepsia and epigastric pain are common emergency department (ED) complaints affecting one in four adults annually. Twenty percent of these patients have an organic cause while 80% have functional dyspepsia (Moayyedi 2017). Antacids are often a first-line treatment in …

Read More
Abdominal and Gastroinstestinal

The HEP-COVID Trial: Therapeutic Anticoagulation in Non-Critically Ill COVID-19 Patients

Background: Patients with COVID-19 are at increased risk from thromboembolic phenomena. Patient-specific factors such as comorbidities and immobility have been linked to thrombosis. Disease-specific factors such as virus-induced endothelial changes and cytokine storm may also be triggers. Furthermore, patients with elevated …

Read More
Hematology and OncologyInfectious DiseaseThoracic and Respiratory

REBEL Cast Book Club Episode 2 — The New Jim Crow

Read More

Ketorolac for Acute MSK Pain: 15mg IM vs 60mg IM

The opioid epidemic has ignited a revolution in ED pain management over the last 5+ years. As such, opportunities for research have become more abundant and have driven ED pain management forward. Regional anesthesia, lidocaine infusions, intranasal ketamine, etc., are …

Read More
Orthopedics

RECOVERY RS: CPAP vs HFNO vs Conventional Oxygen Therapy in COVID-19

Background: Much of the last two years has been both a complete blur and indelibly memorable. This dichotomy is encapsulated by the rapid changes and updates in medical management and hospital algorithms coupled with the memories of frightened faces of …

Read More
Thoracic and Respiratory

Sponsored

0